Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evolent Health, Inc Class A Common Stock (NY:EVH)

3.815 -0.095 (-2.43%)
Streaming Delayed Price Updated: 11:51 AM EDT, May 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks
Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season. 
Via StockStory
News headline image
The Analyst Verdict: Evolent Health In The Eyes Of 16 Experts ↗
 
Via Benzinga
News headline image
1 Growth Stock to Stash and 2 to Keep Off Your Radar
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s... 
Via StockStory
News headline image
Medicare Advantage Rates Expected To Climb Over 5% In 2026, Easing Pressure On Managed Care ↗
CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care. 
Via Benzinga
News headline image
Beyond The Numbers: 18 Analysts Discuss Evolent Health Stock ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 20, 2025 ↗
 
Via Benzinga
News headline image
Evolent Health Stock: A Deep Dive Into Analyst Perspectives (15 Ratings) ↗
 
Via Benzinga
News headline image
What Analysts Are Saying About Evolent Health Stock ↗
 
Via Benzinga
News headline image
1 Healthcare Stock on Our Watchlist and 2 to Turn Down
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
News headline image
Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Phreesia (NYSE:PHR) and its peers. 
Via StockStory
News headline image
3 Reasons to Sell EVH and 1 Stock to Buy Instead
Evolent Health has gotten torched over the last six months - since September 2024, its stock price has dropped 71.1% to $8.76 per share. This was partly due to its softer quarterly results and may have... 
Via StockStory
News headline image
Hims & Hers Health (HIMS) To Report Earnings Tomorrow: Here Is What To Expect
Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings tomorrow afternoon. Here’s what investors should know. 
Via StockStory
News headline image
Cracking The Code: Understanding Analyst Reviews For Evolent Health ↗
 
Via Benzinga
News headline image
Expert Outlook: Evolent Health Through The Eyes Of 7 Analysts ↗
 
Via Benzinga
News headline image
Evolent Health (EVH) Q4 2024 Earnings Call Transcript ↗
EVH earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Evolent Health (NYSE:EVH) Misses Q4 Sales Targets
Healthcare solutions company Evolent Health (NYSE:EVH) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 16.3% year on year to $646.5 million. Next quarter’s revenue guidance... 
Via StockStory
Topics Economy
News headline image
Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For
Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results tomorrow after market close. Here’s what to expect. 
Via StockStory
News headline image
Elevance Health (NYSE:ELV) Posts Q4 Sales In Line With Estimates
Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was... 
Via StockStory
News headline image
Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining ↗
Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week. 
Via Benzinga
News headline image
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul ↗
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates. 
Via Benzinga
News headline image
S&P 500 Tops 6,000; Sezzle Shares Spike Higher ↗
 
Via Benzinga
Topics Stocks
News headline image
Dow Tops 44,000; US Consumer Sentiment Increases In November ↗
 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
US Stocks Mixed; Fluor Earnings Miss Views ↗
 
Via Benzinga
Topics Earnings
News headline image
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Evolent Health (EVH) Q3 2024 Earnings Call Transcript ↗
EVH earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Humana and Evolent Expand Partnership to Enhance Oncology Care
From Evolent Health, Inc.
Via Business Wire
News headline image
Why Is Elevance Health Stock Trading Lower On Thursday? ↗
Evolent Health stock reacted negatively amid Elevance Health's mixed results and Medicaid utilization pressures. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.